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A cDNA clone for the human SmB and B' auto-immune antigens has been isolated by antibody screening ofa eDNA 
expression library. The eDNA clone hybridises with two distinct mRNAs, one f which is expressed in a tissue-specific 
manner. A fusion protein expressed from the eDNA clone was recognised by a number of sera from systemic lupus erythe- 
matosus (SLE) patients containing anti-Sin antibodies but not by sera reactive with other uto-immune antigens. The 
potential use of this clone in a diagnostic assay for SLE and in elucidating the processes regulating the expression f
SmB and B' is discussed. 
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1. INTRODUCTION 
The sera of some patients with connective tissue 
diseases contain auto-antibodies directed against a 
variety of nuclear components [1]. In the case of 
the auto-immune disease, systemic lupus 
erythematosus (SLE), certain patients produce an- 
tibodies which react with the Sm proteins, two of 
which, SmB and B',  are similar in size (28 kDa 
compared to 29 kDa) and closely related to one 
another [2]. Antibodies to the Sm proteins are 
restricted to SLE patients and are therefore con- 
sidered diagnostic for the disease [1]. 
The availability of anti-sera to these proteins has 
allowed the demonstration that they and the small 
nuclear RNAs with which they are associated [3] 
play an essential role in the splicing of mRNA pre- 
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cursors [4]. In agreement with this, SmB has been 
detected in a wide range of tissues and cell types 
[5-7] paralleling the widespread requirement for 
processing of the primary transcript [8]. In contrast 
the closely related SmB' protein is not detectable in
most rodent cell types [5-7]. Recently, however, a 
protein of the size of SmB' and reacting with anti- 
bodies to SmB/B '  has been shown to be expressed 
in a limited range of rodent ceils capable of follow- 
ing an alternative RNA processing pathway [9,10]. 
In particular such cells are capable of producing 
the mRNA encoding the calcitonin gene related 
peptide (CORP) from the primary transcript of the 
calcitonin/CGRP gene whilst most cells are 
capable of splicing this transcript o yield only the 
mRNA encoding calcitonin [11,12]. 
In human cells the situation is more complex 
with all cell types containing both SmB and B ' pro- 
teins [5,6]. However, as we have recently shown [9] 
an acidic isotype of SmB' is expressed in a tissue 
specific manner in humans, its expression being 
confined to the same cell types as those expressing 
Published by Elsevier Science Publishers B. V (Biomedical Division) 
00145793/89/$3.50 © 1989 Federation of European Biochemical Societies 585 
Volume 250, number 2 FEBS LETTERS July 1989 
SmB'  in rodents. Taken together these observa- 
tions suggest a possible role for this tissue specific 
Sm protein in the regulation of  alternative splicing 
allowing the production of  different mRNAs from 
the same primary transcript in different cell types. 
In order to determine the relationship of  this 
tissue-specific protein to the ubiquitous protein 
and to investigate whether this Sm protein plays a 
role in alternative splicing it is necessary to isolate 
cDNA clones derived from the mRNAs encoding 
these proteins. The availability of  such cDNA 
clones which expressed the SmB and B '  polypep- 
tides would also allow the detection of  antibodies 
to these proteins in human sera and might therefore 
be of  use in the diagnosis of  SLE. 
Here we report the use of  a monoclonal  antibody 
to isolate such a cDNA clone expressing the 
SmB/B '  protein as a recombinant fusion protein. 
This clone has been used to examine the relation- 
ship o f  the tissue specific and ubiquitous forms of  
these proteins and to monitor  the reactivity of  
human auto- immune sera. 
2. MATERIALS  AND METHODS 
2.1. Antibody screening and growth of lysogens 
A/~gtll cDNA library prepared from the mRNA of HeLa 
cells (Clontech) was screened with the KSm5 antibody which 
Fig. 1. Western blot of protein samples fron-i lysogenic bacterial 
strains probed with either the KSm5 antibody (panel a) or anti 
fl-galactosidase antibody (panel b). Key to tracks: 1, bacteria 
lysogenized with K5-1 and induced to produce B-galactosidase 
by treatment with IPTG; 2, bacteria lysogenized with K5-1 and 
uninduced; 3, bacteria lysogenized with non-recombinant Agtl 1 
and induced with IPTG; 4, bacteria lysogenized with non- 
recombinant Agtll and uninduced. Arrows indicate the posi- 
tions of marker proteins of the sizes indicated. 
reacts with both SmB and B' [7,9] according to the method of 
Huynh et al. [13]. The single positive plaque obtained in this 
procedure was plaque purified by r peated rounds of creening 
at low density and was used to lysogenise bacteria of E. coli 
strain Y1089 [13]. These bacteria were induced to produce large 
amounts of recombinant fusion protein by treatment with 
10 mM isopropyl-B-D-thiogalacto-pyranoside (IPTG) which is 
an inducer of the lac operon. 
2.2. Western blotting 
Protein isolated from recombinant lysogens wa electro- 
phoresed on 5°70 polyacrylamide-SDS gels [14] and transferred 
to nitrocellulose by electrophoretic transfer [15]. The nitro- 
cellulose filter was reacted as described [16] with antibody K- 
Sm5 or human sera as the first layer and peroxidase conjugated 
anti-mouse or anti-human immunoglobulin as the second layer. 
2.3. Protein purification and sequencing 
SmB protein was purified from rabbit thymus as previously 
described [17] and the N-terminal sequence determined by 
automated Edman degradation on an Applied Bio-systems 
470A gas phase sequencer with on-line analysis of amino acid- 
phenylthiohydantoin derivatives. DNA sequence analysis was 
carried out by the method of Sanger et al. [18] following sub- 
cloning of the insert into MI3 rap18. 
2.4. RNA analysis 
Cytoplasmic mRNA was isolated by the NP40 lysis method 
[19] and analysed by Northern blotting as previously described 
[20]. Blots were hybridised with the 700 base pair insert of K5-1 
which had been radio-labelled by the method of Feinberg and 
Vogelstein [21]. 
3. RESULTS AND DISCUSSION 
To obtain human cDNA clones coding for 
SmB/B '  a monoclonal  anti-Sm antibody, KSm5 
[7], was used to screen a HeLa cell eDNA Agtl I ex- 
pression library. The KSm5 antibody reacts with an 
immunodominant  epitope common to the closely 
related SmB and B'  proteins [7]. Upon screening 
5 x 105 independent ?~gtll recombinants, a single 
positive clone, K5-1, was detected. Isolation of  
DNA from purified K5-1 yielded an EcoRI  insert 
o f  approx. 700 base pairs. 
In the Agtl 1 expression vector, cDNA clones in 
the appropriate reading frame will be expressed as 
a fusion protein with the bacteriophage g- 
galactosidase protein. To confirm that K5-1 did in- 
deed express uch a protein, the recombinant phage 
was used to lysogenize E. coli strain Y1089. After 
growth of  the lysogenic bacteria, they were treated 
with the lac operon inducer IPTG to induce pro- 
duction of  fl-galaetosidase fusion protein, and the 
resulting bacterial lysates were analysed by im- 
munoblott ing with the KSm5 antibody and an anti 
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/3-galactosidase antibody (fig.l). The bacteria 
lysogenic for K5-1, as expected, contained a pro- 
tein reactive with KSm5 which was absent from 
bacteria lysogenized with non-recombinant vector 
(fig. 1 a). This protein was also reactive with anti/3- 
galactosidase antibody (fig.lb) confirming that it 
was a/3-galactosidase-Sm fusion protein. 
The fusion protein was approx. 27 kDa larger 
than native/3-galactosidase indicating that K5-1 
contains most of the coding region for the SmB/B' 
protein. Considerable degradation of the fusion 
protein was observed in the blot with anti /3- 
galactosidase antibody. This phenomenon which 
we have previously observed with other recombi- 
nant fusion proteins [22] is due to the recognition 
of such proteins as foreign by the bacteria and 
results in the rapid removal of the epitope recogniz- 
ed by KSm5 (cf. fig.la and b) which is located at 
the extreme carboxyl-terminus of the Sm protein 
and of the fusion protein (unpublished). In these 
experiments, no reactivity of the fusion protein was 
observed with a monoclonal antibody specific for 
another Sm protein, the 16 kDa SmD protein (not 
shown). 
To prove that the K5-1 cDNA insert represented 
the protein coding sequence for SmB/B' rather 
than being derived from an unrelated protein 
which fortuitously reacted with KSm5, we obtained 
the N-terminal amino acid sequence of affinity 
purified SmB protein (fig.2). Comparison of this 
sequence with the DNA sequence of the K5-1 insert 
obtained by the method of Sanger et al. [18] clearly 
showed a sequence within the K5-1 DNA capable 
of encoding the SmB protein (fig.2). The open 
Met Thr Val Gly Lys Ser Ser Lys Met Leu Gln His Ile Asp Tyr Arg Met Arg Cys Ile 
GAT GGC CGA ATC 
Leu Gln Asp Gly Arg Ile 
ATC CTC TGT GAT TGT GAT 
Ile Leu Cys Asp Cys Asp 
CGC GAA GAA AAG CGG GTT 
Arg Glu Glu Lys Arg Val 
ACT GTG GAG GGG CCA CCC 
Thr Val Glu Gly Pro Pro 
GCT GGA GGC CCT GGG GTT 
Ala Gly Gly Pro Gly Val 
CCC CAG GCC CCT GCT GGA 
Pro Gln Ala Pro Ala Gly 
GTA ATG ACT CCA CAG GGA 
Val Met Thr Pro Gln Gly 
ATT GCT GGA GCC CCA ACA 
Ile Ala Gly Ala Pro Thr 
AGA GCA ACC CCA CCT CCA 
Arg Ala Thr Pro Pro Pro 
CCA CCA ATT GGG CTT GCC 
Pro Pro Ile Gly Leu Pro 
AGA CCC CCT CCA CCA GGC 
Arg Pro Pro Pro Pro Gly 
TTC ATT GGC ACC TTT AAG GCT TTT GAC AAG CAT ATG AAT TTG 
Phe lie Gly Thr Phe Lys Ala Phe Asp Lys His Met Asn Leu 
GAG TTC AGA AAG ATC AAG CCA AAG AAT GCG AAG CAA CCA GAG 
GIu Phe Arg Lys Ile Lys Pro Lys Asn Ala Lys Gln Pro Glu 
TTG GGT CTG GTG TTG CTG CGT GGG GAG AAC TTG GTA TCC ATG 
Leu Gly Leu Val Leu Leu Arg Cly Glu Asn Leu Val Ser Met 
CCC AAA GAT ACT GGC ATT GCT CGG GTA CCA CTT GCT GGA GCT 
Pro Lys Asp Thr Cly Ile Ala Arg Val Pro Leu Ala Gly Ala 
GGT AGG GCA GCT GGT AGA GGA GTA CCA GCT GGT GTG CCA ATT 
Gly Arg Ala Ala Gly Arg Gly Val Pro Ala Gly Val Pro Ile 
TTG GCA GGC CCT GTC CGA GGA GTT GGG GGA CCA TCC CAG CAG 
Leu Ala Gly Pro Val Arg Gly Val Gly Gly Pro Ser Gln Gln 
AGA GGC ACT GTA GCA GCT GCT GCT GTT GCT GCG ACC GCC AGT 
Arg Gly Thr Val Ala Ala Ala Ala Val Ala Ala Thr Ala Ser 
CAG TAC CCA CCA GGA CGG GGC ACT CGG CCC CCA CCC GTC GGC 
Gln Tyr Pro Pro Gly Arg Gly Thr Pro Pro Pro Pro Val Gly 
GGC ATT ATG GCT CCT CCA OCT GGT ATG AGA CCA CCC ATG GGC 
Gly Ile Met Ala Pro Pro Pro Gly Met Arg Pro Pro Met Gly 
CCT GCT CGA GGG ACG CCA ATA GGC ATG CCC CCT CCG GGA ATG 
Pro Ala Arg Gly Thr Pro Ile Gly Met Pro Pro Pro Gly Met 
ATT AGA GGT CCA CCT CCC CCA GGA ATG CGT CCA CCA AGA CCT 
Ile Arg Gly Pro Pro Pro Pro Gly Met Arg Pro Pro Arg Pro 
TAG CATACTGTTGATC ATCTCAGTCACTTTTTC CCTGOAATGCGTCTTGTGAAATTG 
End 
Fig.2. DNA sequence of K5-1 and its predicted amino acid sequence. The N-terminal amino-acid sequence of rabbit SmB protein is 
overlined. Residues 29, 36 and 37 could not be determined unequivocally from the protein sequence and are predicted from the DNA 
sequence. All other residues in the protein sequence match the predicted amino-acid sequence. 
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reading frame encoding the appropriate protein se- 
quence continues for a total of 217 amino acids and 
is followed by 3'-untranslated region indicating 
that although K5-1 lacks the coding information 
for the first 23 amino acids of SmB it is capable of 
encoding most of this protein as predicted from the 
size of the fusion protein it produces. 
Hence K5-1 both reacts with an antibody specific 
for SmB/B'  and contains DNA sequence capable 
of encoding these proteins. It is therefore derived 
from an mRNA encoding SmB/B'  and can be used 
to analyze the relationship of these proteins and the 
processes regulating their expression. In particular 
we wished to investigate whether the previously 
observed expression of the StuB' protein in specific 
rodent cell lines and tissues was reflected at the 
mRNA level. To do ~his Northern blot analysis was 
carried out using a labelled insert from K5-1. 
In these experiments (fig.3) a single mRNA of 
1.4 kb reacting with the probe was detected in 
mRNA prepared from mouse liver. Since we have 
Fig.3. Northern blot of mRNA from mouse liver (track 1) or 
mouse PCC3 embryonal carcinoma cells (track 2) probed with 
the insert from KS-1. Arrows indicate the positions of the 28 S 
and 18 S ribosomal RNAs and of the 1.6 kb and 1.4 kb RNA 
species detected by the probe. 
previously shown that this tissue expresses StuB but 
not SmB' [9], this RNA is likely to encode the SmB 
protein. In contrast when the K5-1 probe was 
hybridised to mRNA prepared from an undifferen- 
tiated mouse embryonal carcinoma (EC) cell line 
(PCC3) two mRNA transcripts of approx. 1.6 kb 
and 1.4 kb were detected the larger of which was 
present at considerably greater abundance. Since 
PCC3 cells in common with other EC cells express 
both the tissue specific StuB' protein and the con- 
stitutively synthesized SmB protein [9,10], it is like- 
ly that the larger transcript encodes the tissue 
specific B' protein. The RNA samples gave iden- 
tical single bands when hybridized with probes 
specific for other RNA species such as that en- 
coding cytochrome oxidase indicating that the dif- 
ference in the pattern obtained with the K5-1 probe 
was not due to RNA degradation (not shown). 
Hence these results suggest that the tissue and cell 
specific SmB' protein in rodents is encoded by a 
distinct tissue-specific mRNA species from that 
which codes for SmB. The isolation and sequence 
analysis of cDNA clones representing the two RNA 
species present in EC cells which we are currently 
carrying out should allow determination of the 
relationship between the rodent StuB and B' pro- 
teins. Similarly the use of K5-1 to isolate further 
cDNA clones from the original HeLa cell library 
will allow an analysis of the differences between the 
SmB and B' proteins which are constitutively ex- 
pressed in humans and which are known to be 
closely related [2]. 
Ultimately such studies of the SmB/B' family of 
proteins will pave the way for the elucidation of the 
role of the tissue specific B' protein in the regula- 
tion of alternative splicing. Thus it will be possible 
to introduce recombinant constructs expressing 
this protein into cells which normally lack it and to 
monitor the effect on the ability of such cells to 
carry out alternative RNA splicing. 
In addition to its use in the analysis of the rela- 
tionships and regulation of the Sm proteins, the 
fact that K5-1 expresses the SmB/B'  protein as a 
fusion protein with fl-galactosidase allowed us to 
investigate whether such a fusion protein could be 
used to detect he presence of antibodies to these 
proteins in human sera. In order to do this, im- 
munoblots of the fusion protein were probed with 
a range of human sera containing auto-antibodies 
to different human proteins. The auto-antibody 
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Fig.4. Western blot of protein samples from lysogenic bacteria probed with the KSm5 antibody (panel a), a human serum containing 
anti-Sm antibodies (panel b) and a human serum lacking anti-Sm antibodies but containing antibodies to other small nuclear RNA- 
associated proteins (panel c). Key to tracks: 1, bacteria lysogenized with non-recombinant Agtl1; 2, as track 1 but induced with IPTG; 
3, bacteria lysogenized with KS-l; 4, as track 3 but induced with IPTG. Arrows indicate the positionsof native ~'-galactosidase andof 
the larger Sm-~'-gaiactosidase fusion protein. 
profiles of the sera had been previously determined 
by immunoblotting with protein extracts prepared 
from HeLa cells [23]. In these experiments, all five 
sera tested which exhibited strong reactivity with 
SmB/B'  in the HeLa cell extract also reacted with 
the fusion protein. A representative example of the 
reactivity of such sera is shown in fig.4b. The 
serum tested exhibits reactivity with the inducible 
fusion protein in the IPTG-treated sample (fig.4b, 
track 4) although the strength of the serum is not 
sufficient for it to detect he low level of fusion 
protein present in the untreated sample (fig.4b, 
track 3) which can be detected however, by the 
higher-affinity monoclonal antibody (fig.4a, track 
3). No reactivity of the anti-Sm sera with non- 
recombinant fl-galactosidase was observed in these 
blots, confirming that they were reacting with the 
Sm portion of the recombinant fusion protein (see 
for example, fig.4b, tracks 1 and 2). 
To investigate the specificity of this effect we 
studied the reactivity of the fusion protein with 
other human sera lacking anti-SmB/B' antibodies 
but containing antibodies to other human proteins. 
In these experiments (fig.4c) the protein failed to 
react with two anti-nRNP sera containing anti- 
bodies to the Ul-associated 70 kDa and A proteins 
which are complexed with the Sm proteins in vivo 
in a single ribonucleoprotein particle, although 
these sera readily detected the appropriate proteins 
in HeLa cell protein samples (not shown). Similarly 
the fusionprotein exhibited no reactivity with sera 
containing antibodies to other common auto- 
antigens such as SS-A (Ro), or SS-B (La) or the 
Epstein-Barr virus protein EBNA-1 reactivity to 
which is commonly present in human sera [1,24]. 
This indicates that the anti-Sm antibodies in SLE 
patient sera invariably include species which 
recognise the Sm epitopes on the fusion protein and 
that such reactivity is specific to anti-Sm anti- 
bodies. Since such antibodies when present in sera, 
are considered iagnostic for SLE, the immuno- 
reactive SmB/B'  fusion protein could be used for 
rapid detection of this disease. 
Thus the fusion protein might provide a cheap 
and reliable source of antigen for use in a highly 
specific diagnostic test for SLE which is currently 
diagnosed by monitoring reactivity of sera with 
total rabbit hymus protein [1]. Moreover the 
absence of any reactivity to non-recombinant d- 
galactosidase in the sixteen sera tested (see for ex- 
ample fig.4, panels b and c) indicates the possibility 
of  using the fusion protein in an ELISA assay of 
the type which has been successfully used to detect 
and quantitate l vels of antibodies to the SS-B (La) 
protein in human sera [25]. 
In summary therefore th  isolation of a cDNA 
clone derived from an mRNA encoding SmB/B'  
should greatly facilitate the study of the relation- 
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ship of the B and B' proteins and their role in RNA 
splicing as well as being of potential diagnostic m- 
portance in human auto-immune disease. 
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